Testing the effect of a new brain stimulation technique on memory and function in people with early Alzheimer’s disease and amnestic mild cognitive impairment.
- Conditions
- Early Alzheimer's DiseaseAmnestic Mild Cognitive ImpairmentNeurological - Alzheimer's diseaseNeurological - Other neurological disorders
- Registration Number
- ACTRN12622000348752
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 24
To be included in the study, participants must meet all of the following inclusion criteria:
•Capable of understanding and signing an informed consent form, as assessed by the informed consent questionnaire.
•A diagnosis of ‘probable’ or ‘possible’ Alzheimer’s disease based on National Institute on Aging and Alzheimer’s Association (NIA-AA) guidelines or a diagnosis of amnestic mild cognitive impairment
•A score of 0.5-1 in the Clinical Dementia Rating scale
•A score of 72 points or higher on the Addenbrooke’s Cognitive Examination (ACE-III, a screening instrument for dementia)
•A score higher than 18 points in the Mini-Mental State Exam (MMSE)
Participants who meet any of the following conditions will be excluded:
•History of epilepsy or seizures
•History of stroke or tumour
•Unstable medical or psychiatric conditions
•Presence of any pacemaker or defibrillator
•Presence of any metal implant in the body
•Alcohol or substance abuse
•Dyslipidaemia
•History of uncontrolled/untreated hypertension
•Participants who, in the opinion of the investigators, do not understand the information and procedures of the study, or would not be compliant with them.
•Any participant for whom the investigators believe, for any reason, that participation would not be an acceptable risk.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method